AIThe Motley Foolabout 3 hours ago
Trump bull market may end but Eli Lilly and another stock will outperform
1 min read
The S&P 500 has gained 23% since Trump's inauguration and its Shiller CAPE ratio remains at historic highs. Inflation and high valuations suggest the bull market may end soon. Eli Lilly, up 1.56%, leads in obesity drugs with Mounjaro and Zepbound, both based on tirzepatide, a GLP-1 drug that targets hormonal digestion pathways.
Level
Hype check
Tap to vote and see what everyone thinks.
